期刊文献+

血液分离碳青霉烯类耐药肺炎克雷伯菌耐药机制及同源性研究 被引量:14

Drug resistance mechanisms and homology of carbapenem-resistant Klebsiella pneumoniae isolated from blood specimens
原文传递
导出
摘要 目的探究血流感染碳青霉烯类耐药肺炎克雷伯菌(CRKP)的耐药性、耐药机制及同源性,以指导临床合理使用抗菌药物。方法收集某院2015-2017年临床分离自血液标本的非重复性CRKP,拉丝试验筛查高毒力肺炎克雷伯菌。改良碳青霉烯灭活法(mCIM)检测碳青霉烯酶表型,PCR法检测血清型基因(K1、K2、K20、K54等)及碳青霉烯酶基因(blaKPC、blaIMP、blaVIM、blaNDM、blaOXA-48等),rep-PCR分析同源性。结果共收集到46株CRKP,主要来源于ICU(43.5%)。CRKP除对磺胺甲噁唑/甲氧苄啶和替加环素有较高的敏感性外,对其余抗菌药物的耐药率均大于60.0%。mCIM试验阳性率为93.5%。blaKPC、blaIMP、blaNDM、blaVIM基因阳性,检出率依次为65.2%、13.0%、10.9%、4.4%。1株同时携带blaKPC、blaIMP,1株同时携带blaKPC、blaVIM,1株同时携带blaIMP、blaNDM,1株同时携带blaIMP、blaVIM。4种血清型基因被检出,K1、K2、K20、K54的检出率分别为4.4%、4.4%、4.4%、2.2%。rep-PCR结果显示46株CRKP分为A^F 6个型,以A型为主(80.4%),主要分布于ICU。值得注意的是,其中1株CRKP被鉴定为碳青霉烯类耐药高毒力肺炎克雷伯菌(carbapenem-resistant hypervirulent K.pneumoniae, CR-hvKP),血清型基因为K2。结论医院血液分离CRKP的耐药性已十分严重,与其携带blaKPC、blaIMP、blaNDM密切相关,且可能存在克隆性传播。同时,临床已分离出CR-hvKP,应该引起高度重视。 OBJECTIVE To explore the drug resistance,drug resistance mechanisms and homology of carbapenem-resistant Klebsiella pneumoniae(CRKP)causing bloodstream infection so as to provide guidance for reasonable use of antibiotics.METHODS Non-repetitive CRKP strains that were isolated from blood specimens from 2015 to 2017 were collected,the string test was conducted to identify hypervirulent Klebsiella pneumoniae,the phenotypes of carbapenemase were detected by using the modified carbapenem inactivation method(mCIM),the serotype genes(K1,K2,K20,K54,etc.)and carbapenemase genes(blaKPC,blaIMP,blaVIM,blaNDM,blaOXA-48,etc.)were detected by means of PCR,and the homology of the CRKP strains was analyzed through repeated sequence PCR(rep-PCR).RESULTS A total of 46 strains of CRKP were collected,43.5%of which were isolated from the ICU.The CRKP strains were highly susceptible to trimethoprim-sulfamethoxazole and tigecycline,while the drug resistance rates to other antibiotics were more than 60.0%.The positive rate of mCIM test was 93.5%.The positive rates of detection of blaKPC,blaIMP,blaNDM,and blaVIM were 65.2%,13.0%,10.9%and 4.4%,respectively.One strain co-carried both blaKPC and blaIMP,one strain co-carried both blaKPC and blaVIM,one strain co-carried both blaIMP and blaNDM,and one strain co-carried both blaIMP and blaVIM.Four serotype genes were detected positive,and the detection rates of K1,K2,K20,and K54 were 4.4%,4.4%,4.4%and 2.2%,respectively.The results of rep-PCR showed that 46 strains of CRKP strains were divided into 6 types of A-F,type A(80.4%)was dominant and prevalent in the ICU.It was worth noting that one of the strains was eventually identified as carbapenem-resistant hypervirulent K.pneumoniae(CR-hvKP),with the serotype gene K2.CONCLUSION The CRKP strains that are isolated from the blood specimens have been highly drug-resistant,which is closely associated with the carrying with blaKPC,blaIMP and blaNDM,and worse more,and there might be clonal propagation.The CR-hvKP strains have been emerged,which should be attached great importance to.
作者 李军 黄紫嫣 谭媛 陶晓燕 胡咏梅 王海晨 刘文恩 邹明祥 LI Jun;HUANG Zi-yan;TAN Yuan;TAO Xiao-yan;HU Yong-mei;WANG Hai-chen;LIU Wen-en;ZOU Ming-xiang(Xiangya Hospital,Central South University,Changsha,Hunan 410008,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2019年第17期2561-2565,2593,共6页 Chinese Journal of Nosocomiology
基金 国家自然科学基金青年科学基金资助项目(81702068) 湖南省自然科学基金资助项目(2017JJ3478) 中南大学大学生创新类资助项目(ZY20171022)
关键词 血流感染 肺炎克雷伯菌 碳青霉烯类耐药 耐药机制 同源性 Bloodstream infection Klebsiella pneumoniae Carbapenem resistance Drug resistance mechanism Homology
作者简介 通信作者:邹明祥,E-mail:zoumingxiang@126.com
  • 相关文献

参考文献2

  • 1胡付品,郭燕,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,邹凤梅,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍,郭大文,赵金英,刘文恩,李艳明,金炎,邵春红,温开镇,张贻荣,徐雪松,鄢超,喻华,黄湘宁,王山梅,楚亚菲,张利侠,马娟,周树平,周艳,朱镭,孟晋华,董芳,郑红艳,沈瀚,周万青,贾伟,李刚,吴劲松,卢月梅.2017年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251. 被引量:442
  • 2衣美英,李杰,王靖,贾红兵,李春英,张悦娴,鄢盛恺.耐碳青霉烯类抗生素肺炎克雷伯菌的耐药机制和同源性研究[J].中国感染与化疗杂志,2012,12(4):297-301. 被引量:19

二级参考文献16

  • 1CLSI. Performance standards for antimierobial susceptibility test ing ; Twentieth informational supplement (2010) [ S]. CLSI document. WayIIe, PA: Clinical and Laboratory Standards Institute. 2010.
  • 2Smith Moland E, Hanson ND, Herrera VL, et al. Plasmidmediated carbapenem hydrolysing bate lactamases KPC-2 in Klebsiella pneumomae isolates[J].J Antimicrob Chemother, 2003, 51(3):711- 714.
  • 3Sader HS, Reis AO, Silbert S, et al. IMPs, VIMs and SPMs: the diversity of metallo-beta lactamases produced by carbapenem resistant Pseudomcnas aeruginosa in a Brazilian hospital[J]. Clin Microbiol Infect, 2005,11 ( 1 ) :73-76.
  • 4Marlana C, Mark AT, RonMd NJ, et al. Molecular characterization of a β-laetamases gene, BlaGIM-1, encoding a new subclass of metallo lactamase[J]. Antimierob Agents Chemother, 2004,48(12) : 4654- 4661.
  • 5Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo beta lactamase g ene, bla(NDM-1 ), and a no vel erythromycin esterase gent carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from In dia[J]. Antimicrob Agents Chemother, 2009, 53 (12) : 5046-5054.
  • 6Bou G, Cervero G, Dominguez MA, et al. Characterization of a nosocomial outbreak caused by a multiresistant Acineto bacter baumannii strain with carbapenem hydrolyzing en- zyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases[J]. Clin Microbiol, 2000,38 : 3299-3305.
  • 7Kumarasamy KK, Toleman MA,walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India,Pakistan, and the UK:a molecular, biological, and epidemiological study [J]. Lancet Infect Dis, 2010,10(9):597- 602.
  • 8Mendes RE, Bell JM, Tumidge J D, et al. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a eonjugative plasmid(blaKPC 2 plus qnrB4) and a blaIMP 4 gene[J].Antimicrob Agents Chemother, 2008,52 (2) : 798- 799.
  • 9Chen LR,Zhou HW,Cai jc, et al. Combination of IMP 4 metallo beta lactamase production and porin deficiency causes earbapenem resistance in a Kdebsiella oxytoca clinical isolate [J]. Diagn Microbiol Infect Dis, 2009, 65(2): 163-167.
  • 10Ratkai C, Quinteira S, Grosso F, et al. Controlling for false positives: interpreting MBL Etest and MBI. combined disc test for the detection of metallo-beta-lactamases[J]. J Antimicrob Chemother, 2009, 64(3):657-658.

共引文献458

同被引文献91

引证文献14

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部